-
-
Humanized model of the immune system
-
iHuPBMC-T
-
iHuPBMC-NK
-
iHuPBMC-B
-
PBMC-LT
-
CD34+ HSC
-
Winn model
-
iHuPBMC-MHC/KO
-
iHuPBMC-OncVax
-
PBMC mixed inoculation model
more -
-
In vivo tumor experimental platform
-
CDX
-
iHuPDX
-
Non-GLP Toxicology
-
PK/PD
-
Brain in situ model
-
Other in situ models
-
Hematologic tumor model system inoculation
-
Creation of high interstitial tumor models
more -
-
In vitro killing experiment platform
-
Immune co-culture killing model
-
CDC
-
In vitro killing experiment platform
-
IC50
-
PDC High-Throughput In Vitro Pharmacodynamics
-
3D organoids
-
ADCC
-
T cell-mediated killing experiment
more -
-
Mouse-derived immune system model
more -
Tumor vaccine
more -
Cell therapy
more -
In vitro testing platform
more -
Non-GLP Toxicology Platform
more -
Non-tumor model and drug efficacy evaluation platform
-
Systematic Vaccination Model
-
Non-tumor model and drug efficacy evaluation platform
-
Skin injury model
-
Stroke model
-
Liver fibrosis model
-
Diabetes model
-
Gouty Arthritis (GA) Model
-
Pulmonary fibrosis model
-
Systemic lupus erythematosus (SLE) model
-
Inflammatory Bowel Disease (IBD) model
-
Rheumatoid Arthritis (RA) Model
more -
-
-
-
PDX model
-
PDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
CDX model
-
CDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
Homogeneous Model
-
Homogeneous Model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Breast cancer
-
Stomach cancer
-
Liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Pancreatic cancer
-
Kidney cancer
-
Bladder cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer
-
Ovarian cancer
-
Esophageal cancer
-
Skin cancer
-
sarcoma
-
Nervous System Cancer
-
Embryonal carcinoma
-
Lymphoma
-
Leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other
-
Colorectal cancer
more -
-
News Center
——
What are the characteristics of the in vitro killing experimental platform of InnoModels Biotechnology Company
Author:
InnoModels
Release time:
2024-07-30
In the fields of life science research and drug development, in vitro killing experimental platforms are important tools for evaluating drug efficacy and studying cellular mechanisms. InnoModels Biotechnology (Beijing) Co., Ltd., with its strong research and innovation capabilities, has launched multiple in vitro killing experimental platforms, providing researchers with highly controllable and accurate experimental environments, greatly promoting the development of this field. This article will provide a detailed introduction to the characteristics of the InnoModels organism in vitro killing experimental platform.
1. Highly controllable experimental environment
One of the most significant features of the in vitro killing experimental platform of InnoModels Biotechnology is its highly controllable experimental environment. This platform can accurately regulate key factors such as temperature, humidity, and atmosphere to ensure the accuracy and reproducibility of experimental results. This precise regulation not only helps reduce experimental errors, but also enables researchers to more accurately simulate the in vivo environment and improve the physiological relevance of experimental results.
2. Supports multiple cell types
This platform supports applications for multiple cell types, including but not limited to tumor cells, primary cells, and immune cells. This broad applicability enables researchers to conduct extensive research in different fields, whether it is oncology, immunology, or drug development, and find suitable experimental models. Through mixed culture, such as PBMC tumor cell co culture, the platform can more accurately simulate the in vivo immune-mediated killing response, providing strong support for the research and development of immunotherapy.

3. Real time monitoring and data analysis
During the experiment, the in vitro killing experimental platform of InnoModels Biotechnology can monitor cell status and response in real time, while recording and analyzing data. This real-time feedback mechanism not only improves the efficiency and accuracy of the experiment, but also enables researchers to adjust the experimental plan in a timely manner and optimize the experimental conditions. The application of advanced detection technologies such as flow cytometry enables researchers to accurately distinguish between effector cells and target cells, and accurately evaluate the killing effect.
4. Advanced automation technology
This platform adopts advanced automation technology, making the experimental process more efficient and convenient. Automated operations not only reduce errors caused by human factors, but also improve the reliability and repeatability of experiments. In addition, the introduction of automation technology enables the platform to process large-scale experimental data, providing strong data support for new drug screening and drug mechanism research.
5. Wide range of application areas
The in vitro killing experimental platform of InnoModels Biotechnology has been widely used in multiple fields. In terms of drug screening, researchers can use this platform to evaluate the cytotoxicity and toxicity levels of drugs on cells, providing important data for safety assessment in the drug development process. In terms of immunological research, this platform can be used to evaluate the killing potential of immune cells against tumor cells, providing strong support for the development and evaluation of immunotherapy. In addition, the platform is widely used in the field of personalized medicine, tailoring treatment plans based on individual patients' immune responses to improve treatment outcomes.
epilogue
The in vitro killing experimental platform of InnoModels Biotechnology has demonstrated strong competitiveness in the fields of life science research and drug development due to its highly controllable experimental environment, support for multiple cell types, real-time monitoring and data analysis, advanced automation technology, and wide range of application areas. This innovative platform not only provides researchers with efficient and reliable experimental tools, but also promotes progress and development in the field of science. In the future, with the continuous advancement of technology and the deepening of applications, the in vitro killing experimental platform of InnoModels Biotechnology is expected to play an important role in more fields and make greater contributions to human health.
Previous Page
InnoModels Biotechnology (Beijing) Co., Ltd.
-
TEL: +86 15711355061
-
E-mail: xuyl@imodels.tech
-
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
InnoModels Biotechnology (Beijing) Co., Ltd